000 | 02009 a2200517 4500 | ||
---|---|---|---|
005 | 20250515135742.0 | ||
264 | 0 | _c20090225 | |
008 | 200902s 0 0 eng d | ||
022 | _a1600-6143 | ||
024 | 7 |
_a10.1111/j.1600-6143.2008.02411.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZarkhin, V | |
245 | 0 | 0 |
_aA randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation. _h[electronic resource] |
260 |
_bAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _cDec 2008 |
||
300 |
_a2607-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
650 | 0 | 4 |
_aAntigens, CD20 _xmetabolism |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGraft Rejection _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aKidney _xpathology |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aTransplantation, Homologous |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aLi, L | |
700 | 1 | _aKambham, N | |
700 | 1 | _aSigdel, T | |
700 | 1 | _aSalvatierra, O | |
700 | 1 | _aSarwal, M M | |
773 | 0 |
_tAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _gvol. 8 _gno. 12 _gp. 2607-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-6143.2008.02411.x _zAvailable from publisher's website |
999 |
_c18276045 _d18276045 |